International Stem Cell ISCO
OTC ISCO
$0.33 -0.02 (-5.71%)
At close: Sep 28, 2026 · 4:00 PM EDT

International Stem Cell (ISCO) Operating Interest Expenses (2013 - 2016)

Updated

International Stem Cell (ISCO) posted Operating Interest Expenses of $928,000 for FY2016.

Analysis

International Stem Cell (ISCO) Operating Interest Expenses (2013 - 2016) Analysis & Trends

  • Annual Operating Interest Expenses shows a three-year compound annual growth rate of 7.9% (FY2013 to FY2016).
  • The FY2016 figure stands as the lowest annual Operating Interest Expenses since FY2013.
  • Business Quant data shows ISCO's Operating Interest Expenses at $997,000 in FY2014 (+35.1%) and $738,000 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 International Stem Cell 2.64 Mn -1.33 Mn 1.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 59,000.00
Mar 31, 2016 869,000.00
Sep 30, 2013 738,000.00
API Access

International Stem Cell Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=ISCO&period=max&api_key=YOUR_API_KEY